KKR Group Ltd
10% Owner
KKR Group Ltd10% Owner
KKR Group Ltd insider trades: Amedisys (AMED) stock buys and sales
10% Owner, Amedisys Last trade Jun 4, 2018 101 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
103
Open-market trades
since 2009
26
Companies
last trade 2018
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where KKR Group Ltd reports to the SEC
RNETRigNet
Insider · last filing Jul 2, 2018
No market trades
KREFKKR Real Estate Finance Trust
Insider · last filing Jul 2, 2018
No market trades
WMIHWmih
Insider · last filing Jul 2, 2018
No market trades
BVBrightView Holdings
Insider · last filing Jul 2, 2018
No market trades
EGLEngility Holdings
Insider · last filing Jul 2, 2018
No market trades
FDCFirst Data
Insider · last filing Jul 2, 2018
No market trades
and 20 more companies
Open-market buys and sales
103 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 4, 2018 | AMED | ↓ Sell | 2,437,424 | $73.96 | $180.3M | Indirect | Jun 6, 2018 (2d) |
| May 23, 2018 | GDDY | ↓ Sell | 4,000,000 | $70.73 | $282.9M | Indirect | May 25, 2018 (2d) |
| May 7, 2018 | GDI | ↓ Sell | 30,436,064 | $29.84 | $908.1M | Indirect | May 9, 2018 (2d) |
| Mar 26, 2018 | EYE | ↓ Sell | 1,444,822 | $31.68 | $45.8M | Indirect | Mar 28, 2018 (2d) |
| Mar 19, 2018 | EYE | ↓ Sell | 9,632,145 | $31.68 | $305.1M | Indirect | Mar 21, 2018 (2d) |
| Mar 5, 2018 | GDDY | ↓ Sell | 5,000,000 | $59.21 | $296.0M | Indirect | Mar 7, 2018 (2d) |
| Dec 4, 2017 | USFD | ↓ Sell | 19,977,772 | $28.00 | $559.4M | Indirect | Dec 6, 2017 (2d) |
| Nov 20, 2017 | GDI | ↓ Sell | 25,250,880 | $26.43 | $667.4M | Indirect | Nov 22, 2017 (2d) |
| Sep 18, 2017 | USFD | ↓ Sell | 20,000,000 | $27.34 | $546.8M | Indirect | Sep 20, 2017 (2d) |
| Sep 8, 2017 | GDDY | ↓ Sell | 5,809,272 | $43.71 | $253.9M | Indirect | Sep 12, 2017 (4d) |
| Aug 14, 2017 | PRAH | ↓ Sell | 9,500,000 | $74.85 | $711.1M | Indirect | Aug 16, 2017 (2d) |
| May 17, 2017 | USFD | ↓ Sell | 22,655,559 | $27.40 | $620.8M | Indirect | May 19, 2017 (2d) |
| May 10, 2017 | GDDY | ↓ Sell | 8,004,645 | $37.44 | $299.7M | Indirect | May 12, 2017 (2d) |
| Apr 19, 2017 | HCC | ↓ Sell | 2,389,274 | $17.81 | $42.6M | Indirect | Apr 21, 2017 (2d) |
| Feb 6, 2017 | LAUR | ↑ Buy | 3,571,428 | $14.00 | $50.0M | Indirect | Feb 8, 2017 (2d) |
| Jan 31, 2017 | USFD | ↓ Sell | 20,700,000 | $25.09 | $519.4M | Indirect | Feb 2, 2017 (2d) |
| Nov 16, 2016 | PRAH | ↓ Sell | 7,500,000 | $55.51 | $416.3M | Indirect | Nov 18, 2016 (2d) |
| May 10, 2016 | HCA | ↓ Sell | 9,360,958 | $80.12 | $750.0M | Held through Hercules Holding II, LLC an | May 12, 2016 (2d) |
| May 6, 2016 | PRAH | ↓ Sell | 4,907,692 | $46.70 | $229.2M | Indirect | May 10, 2016 (4d) |
| Apr 12, 2016 | GDDY | ↓ Sell | 4,920,833 | $29.27 | $144.0M | Indirect | Apr 14, 2016 (2d) |
| Mar 8, 2016 | PRAH | ↓ Sell | 4,829,981 | $42.26 | $204.1M | Indirect | Mar 10, 2016 (2d) |
| Sep 25, 2015 | SJM | ↓ Sell | 8,277,495 | $113.31 | $937.9M | Held through Blue Holdings I, L.P. | Sep 25, 2015 (0d) |
| Mar 5, 2015 | NLSN | ↓ Sell | 4,000,000 | $45.00 | $180.0M | Indirect | Mar 9, 2015 (4d) |
| Sep 8, 2014 | SC | ↓ Sell | 5,023,977 | $18.65 | $93.7M | Indirect | Sep 10, 2014 (2d) |
| May 23, 2014 | HCA | ↓ Sell | 14,777,314 | $51.53 | $761.5M | Held though Hercules Holding II, LLC and | May 28, 2014 (5d) |
| Mar 10, 2014 | NLSN | ↓ Sell | 6,198,292 | $46.25 | $286.7M | Indirect | Mar 12, 2014 (2d) |
| Jan 28, 2014 | SC | ↓ Sell | 24,392,927 | $23.04 | $562.0M | Indirect | Jan 30, 2014 (2d) |
| Nov 26, 2013 | NLSN | ↓ Sell | 6,198,292 | $39.09 | $242.3M | Indirect | Nov 29, 2013 (3d) |
| Nov 21, 2013 | AMED | ↑ Buy | 425,515 | $14.48 | $6.2M | Indirect | Nov 21, 2013 (0d) |
| Nov 14, 2013 | AMED | ↑ Buy | 946,500 | $13.89 | $13.2M | Indirect | Nov 14, 2013 (0d) |
| Nov 1, 2013 | HCA | ↓ Sell | 20,328,218 | $46.92 | $953.8M | Held though Hercules Holding II, LLC and | Nov 5, 2013 (4d) |
| Oct 30, 2013 | AMED | ↑ Buy | 29,615 | $15.94 | $472K | Indirect | Oct 31, 2013 (1d) |
| Oct 22, 2013 | AMED | ↑ Buy | 186,013 | $17.55 | $3.3M | Indirect | Oct 23, 2013 (1d) |
| Oct 18, 2013 | AMED | ↑ Buy | 12,652 | $17.95 | $227K | Indirect | Oct 21, 2013 (3d) |
| May 17, 2013 | NLSN | ↓ Sell | 8,313,661 | $34.48 | $286.7M | Indirect | May 21, 2013 (4d) |
| Apr 3, 2013 | DG | ↓ Sell | 13,375,879 | $50.14 | $670.7M | Held through Buck Holdings, L.P. and KKR | Apr 5, 2013 (2d) |
| Apr 3, 2013 | DG | ↓ Sell | 1,609,088 | $50.14 | $80.7M | Held through Buck Holdings, L.P. and Buc | Apr 5, 2013 (2d) |
| Apr 3, 2013 | DG | ↓ Sell | 376,187 | $50.14 | $18.9M | Held through Buck Holdings, L.P. and 8 N | Apr 5, 2013 (2d) |
| Mar 18, 2013 | ZZ | ↓ Sell | 46,625,921 | $2.20 | $102.6M | Indirect | Mar 20, 2013 (2d) |
| Mar 8, 2013 | JAZZ | ↓ Sell | 3,750,000 | $58.28 | $218.6M | Indirect | Mar 12, 2013 (4d) |
| Feb 21, 2013 | NLSN | ↓ Sell | 8,430,338 | $31.57 | $266.2M | Indirect | Feb 25, 2013 (4d) |
| Feb 15, 2013 | HCA | ↓ Sell | 23,884,751 | $35.87 | $856.7M | Held though Hercules Holding II, LLC and | Feb 20, 2013 (5d) |
| Dec 14, 2012 | HCA | ↓ Sell | 15,286,241 | $33.00 | $504.4M | Held though Hercules Holding II, LLC and | Dec 18, 2012 (4d) |
| Dec 12, 2012 | AVGO | ↓ Sell | 4,339,604 | $34.43 | $149.4M | Held through KKR European Fund, Limited | Dec 13, 2012 (1d) |
| Dec 12, 2012 | AVGO | ↓ Sell | 2,950,886 | $34.43 | $101.6M | Held through KKR European Fund II, Limit | Dec 13, 2012 (1d) |
| Dec 12, 2012 | AVGO | ↓ Sell | 2,209,597 | $34.43 | $76.1M | Held through KKR Millennium Fund (Overse | Dec 13, 2012 (1d) |
| Dec 12, 2012 | AVGO | ↓ Sell | 1,506,428 | $34.43 | $51.9M | Held through Avago Investment Partners, | Dec 13, 2012 (1d) |
| Dec 12, 2012 | AVGO | ↓ Sell | 390,665 | $34.43 | $13.5M | Held through KKR Partners (International | Dec 13, 2012 (1d) |
| Nov 30, 2012 | DG | ↓ Sell | 4,263,202 | $50.04 | $213.3M | Held through Buck Holdings, L.P. and KKR | Dec 3, 2012 (3d) |
| Nov 30, 2012 | DG | ↓ Sell | 512,854 | $50.04 | $25.7M | Held through Buck Holdings, L.P. and Buc | Dec 3, 2012 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About KKR Group Ltd's insider trades
KKR Group Ltd is a 10% owner of Amedisys (AMED). Since Nov 18, 2009, it has reported 7 open-market purchases worth $98.3M and 96 sales worth $23.27B on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (37 filings), conversions (7 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.